Received Jul 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Y012865 | OT / LA |
presented with a rash located at injection site, under belly, arms, and legs.; presented with a rash located at injection site, under belly, arms, and legs.; This spontaneous report was received from a medical assistant and referred to a 16-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 24-Mar-2025, the patient was vaccinated with a dose of Human Papillomavirus 9-valent Vaccine, Recombinant Injection (GARDASIL 9) (lot #Y012865, expiration date: 10-Oct-2026, 0.5ml/ series, intramuscular injection left arm) for prophylaxis. On unknown date in April 2025 (sometime during the first week of April 2025), the patient presented with a rash located at injection site, under belly, arms, and legs. The patient sought medical attention. On unknown date in 2025 (a few days later), the patient recovered fully from the events with no intervention. The action taken with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) was reported as not applicable. The causal relationship between all events and Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) was not provided.